Using the inter-eye percentage difference may help surpass limitations associated with device and proprietary segmentation algorithms.
Opicinumab may potentially enhance spontaneous remyelination after acute optic neuritis.
There were no significant associations for alternative risk factors after controlling for radiation dosage.
There was a significant association between the average GCIP thickness and MSFC scores.
While the effect is modest, researchers believe the findings will influence future repair studies.
Those treated with phenytoin saw a 30% reduction in retinal nerve fiber loss.
The drug was tested in patients with optic neuritis, but is now being evaluated in patients with multiple sclerosis.
An anti-LINGO-1 monoclonal antibody showed some success in treating optic neuritis but missed many study endpoints.
Neurology Advisor Articles
- Clarifying Cardiovascular Risk in Migraine
- Parkinson Disease Symptom Fluctuations Well-Managed With Adaptive Deep Brain Stimulation
- More Evidence Supports Benefits of Cannabidiol for Treatment-Resistant Epilepsy
- Monthly Erenumab Reduces Frequency of Episodic Migraine
- Reduced Risk for Multiple Sclerosis Linked to Greater Sun Exposure
- Tamsulosin Associated With Dementia Risk in Older Patients With BPH
- FDA Approves Blood Test to Assess Concussion
- Gait Difficulty in Parkinson Disease May Be Associated With More Progressive Disease Course
- Tau PET a Useful Biomarker for Alzheimer Disease Risk and Progression
- Multiple Sclerosis Drug Zinbryta Withdrawn From the Market
- Incidence of Delayed Traumatic Intracranial Hemorrhage Low in Older Adults With Blunt Head Trauma
- Older Epilepsy Patients More Likely to Experience AED, Non-AED Drug Interaction
- Female Gender, Natalizumab Exposure Associated With Increased Lymphopenia Risk in FNG-Treated MS
- Accelerated Cognitive Decline Associated With Retinopathy
- Treatment Effects Often Exaggerated in Early Clinical Studies